Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes

(2015) Laurens Sand et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis

(2015) Elena Tutunea-Fatan et al.   Molecular Cancer

CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells

(2015) Miao Mo et al.   PLoS One

The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth

(2015) Michal Hameiri-Grossman et al.   Oncotarget

The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

(2015) Leisha A. Emens et al.   Cancer Immunology Research

Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer

(2014) Ping Chen et al.   CANCER SCIENCE

Let-7a Functions as a Tumor Suppressor in Ewing's Sarcoma Cell Lines Partly by Targeting Cyclin-Dependent Kinase 6

(2014) Zhongzu Zhang et al.   DNA AND CELL BIOLOGY

Phase I Trial of Trans-thoracic Injection of CCL21 Gene Modified Dendritic Cells in Human Non-small Cell Lung Carcinoma

(2014) J.M. Lee et al.   JOURNAL OF SURGICAL RESEARCH

Differentially Expressed miRNAs in Ewing Sarcoma Compared to Mesenchymal Stem Cells: Low miR-31 Expression with Effects on Proliferation and Invasion

(2014) Bianca Karnuth et al.   PLoS One

The Lymphoid Chemokine CCL21 Enhances the Cytotoxic T Lymphocyte-Inducing Functions of Dendritic Cells

(2014) C. Y. Hong et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

CCL21 Cancer Immunotherapy

(2014) Yuan Lin et al.   Cancers

Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity

(2013) Jens H. W. Pahl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

(2013) Yuting Ma et al.   IMMUNITY

Mutational heterogeneity in cancer and the search for new cancer-associated genes

(2013) Michael S. Lawrence et al.   NATURE

Accumulation of pre-let-7g and downregulation of mature let-7g with the depletion of EWS

(2012) Eun Jung Sohn et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors

(2012) C. H. Evans et al.   CLINICAL CANCER RESEARCH

A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

(2011) Walayat Shah et al.   Cellular & Molecular Immunology

Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development

(2011) Claudio De Vito et al.   PLoS One

Double Duty for CCL21 in Dendritic Cell Trafficking

(2010) Philip M. Murphy   IMMUNITY

Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression

(2010) Dagmar Berghuis et al.   JOURNAL OF PATHOLOGY

Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21

(2010) J. D. Shields et al.   SCIENCE

Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort

(2009) Laura Ottaviano et al.   GENES CHROMOSOMES & CANCER

The Human Protein Atlas-a tool for pathology

(2008) F Pontén et al.   JOURNAL OF PATHOLOGY

NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways

(2008) Dirk H.J. Verhoeven et al.   MOLECULAR IMMUNOLOGY